Kura Oncology KURA Growth Metrics (2010-2026)

NASDAQ KURA
$10.71 -0.10 (-0.93%)
At close: Sep 30, 2026 · 4:00 PM EDT
Reported Financials

Kura Oncology Quarterly Growth Metrics

Periods 26 quarters
Latest Jun 2026

Kura Oncology growth metrics data for the quarter ended Jun 2026. These growth metrics cover 26 quarters of results from Dec 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
EBITDA Margin Growth (1y)
2,733.0012,585.00
EBITDA Margin (QoQ)
-1695.0011,935.00-10800.003,294.008,157.00
EBIT Margin Growth (1y)
2,710.0012,555.00
EBIT Margin (QoQ)
-1671.0012,002.00-10953.003,332.008,174.00
EBT Margin Growth (1y)
401.0010,520.00
EBT Margin (QoQ)
-2704.007,532.00-10963.006,537.007,414.00
FCF Margin Growth (1y)
4,115.00-10502.00
FCF Margin (QoQ)
31,413.00-20317.00106,402.00-113383.0016,795.00
Gross Margin Growth (1y)
-143.00-116.00
Gross Margin (QoQ)
0.0027.00
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
39.57%37.74%25.85%-0.05%-7.43%26.91%25.34%32.25%24.48%-6.46%94.57%-37.22%-49.62%-43.15%-458.81%-38.49%-13.87%
Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y)
30.50%28.95%19.12%21.15%21.46%68.92%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
-4.74%6.32%-77.02%42.40%-12.47%36.27%-80.82%47.73%-25.37%10.16%90.78%-0.63%-5.50%68.20%-306.39%-9.73%-0.94%-24.15%-0.72%9.78%
Net Margin Growth (1y)
557.0010,518.00
Net Margin (QoQ)
-2544.007,532.00-11004.006,574.007,416.00
Operating Margin Growth (1y)
2,710.0012,555.00
Operating Margin (QoQ)
-1671.008,174.00
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
8,597.00380.003,708.00-27753.00-11623.002,571.003,823.009,473.00-23759.00-7976.0022,877.00-1403.00-858.00-112.00-1240.00-1844.00-2049.00
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
-26785.00-5026.0030,408.00
Return on Assets [ROA] (QoQ)ROA (QoQ)
4,174.00-6156.00-8124.00-17646.0020,304.008,038.00-6872.00-11996.00-12928.0023,820.0023,981.00-890.00-1236.00339.00384.00-345.00-490.00-789.00-220.00-550.00
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
-1760.00-1448.00-821.00-1906.00-2341.00-2663.00
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
-940.00-1376.00213.00342.00-628.00-749.00-871.00-92.00-950.00
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
-3525.00-3758.00-4362.00-9269.00-16267.00-32145.00
Return on Equity [ROE] (QoQ)ROE (QoQ)
-969.00-1412.00-628.00-517.00-1203.00-2015.00-5534.00-7515.00-17081.00
Return on Invested Capital [ROIC] (QoQ)ROIC (QoQ)
-6908.00-14531.00
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
2,710.0012,555.00
Return on Sales [ROS] (QoQ)ROS (QoQ)
-1671.0012,002.00-10953.003,332.008,174.00

Kura Oncology Growth Metrics API

Pull Kura Oncology's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=KURA&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY